Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
12,97 USD | +1,89% |
|
-7,36% | +170,21% |
Attività
Numero di dipendenti: 1 543
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Vaccines
100,0
%
| 1 982 | 100,0 % | 984 | 100,0 % | -50,36% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 982 | 100,0 % | 984 | 100,0 % | -50,36% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
John Jacobs
CEO | Chief Executive Officer | 57 | 23/01/23 |
John Trizzino
PSD | President | 64 | 10/03/14 |
James Kelly
DFI | Director of Finance/CFO | 58 | 16/08/21 |
Troy Morgan
CMP | Compliance Officer | - | 19/04/21 |
Biegie Lee
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Seth Toback
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/20 |
Gale Smith
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/04 |
Raburn Mallory
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Silvia Taylor
IRO | Public Communications Contact | - | 17/06/20 |
Erika Schultz
IRC | Investor Relations Contact | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Richard Rodgers
BRD | Director/Board Member | 57 | 29/10/22 |
Gregg Alton
BRD | Director/Board Member | 58 | 01/11/20 |
David Mott
BRD | Director/Board Member | 58 | 16/06/20 |
James Young
CHM | Chairman | 71 | 07/04/10 |
Margaret McGlynn
BRD | Director/Board Member | 64 | 07/12/20 |
Rachel King
BRD | Director/Board Member | 64 | 01/11/18 |
Richard Douglas
BRD | Director/Board Member | 71 | 06/08/10 |
John Jacobs
CEO | Chief Executive Officer | 57 | 23/01/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 141 745 693 | 133 406 786 ( 94,12 %) | 1 327 717 ( 0,9367 %) | 94,12 % |
Coordinate società
![Indirizzo Novavax, Inc.(NVAX)](https://cdn.zonebourse.com/static/address/58256108.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+170,21% | 1,82 Mrd | |
+17,72% | 44,87 Mrd | |
-10,33% | 37,8 Mrd | |
+41,87% | 37,61 Mrd | |
+29,36% | 31,32 Mrd | |
-8,44% | 27,4 Mrd | |
+12,45% | 26,32 Mrd | |
+44,19% | 14,07 Mrd | |
+31,93% | 12,5 Mrd | |
-7,67% | 11,23 Mrd |
- Borsa valori
- Azioni
- Azione NVAX
- Società Novavax, Inc.